New pill hopes to shrink lung tumors in patients who failed other treatments
Disease control
Recruiting now
This early-stage study tests an experimental pill (HJ-004-02) in 36 adults with advanced non-squamous non-small cell lung cancer that has a specific EGFR gene change. Participants take the pill daily in 28-day cycles. The main goals are to check safety and find the right dose, wh…
Phase: PHASE1 • Sponsor: Tongji University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC